Use the TBS-T carrier Filipin III working solution for cell staining. 50 μg/mL of Filipin III was applied to NCI-60 cancer cells while they were in the dark. Use TBS-T to wash the cells after one hour after viral loading. After that, the coverslips were removed and put in a mounting media that contained water. Using the particle size algorithm in the MetaXpress image analysis software (Molecular Devices Corp., Sunnyvale, CA), freezing levels were quantified while images were being captured with an Olympus Provis fluorescence microscope that had a 40X oil objective [2 Huang Y, et al. assessed the migration in relation to TSPAN-GFP's cholesterol enrichment. TSPAN4-GFP-expressing NRK cells were stabilized at 37 °C using 2 μg/mL Filipin III. Following a 15-minute treatment period, TSPAN4-GFP intensity on migrasomes (ItM), filipin III intensity on RFs (IpR), and filipin III intensity on migrasomes (IpM) were measured using confocal microscopy Z-stack images. In order to achieve staining findings, Fibroblast was subjected to 25 μg/ml Filipin III and incubated in the dark for 45 minutes (20°C) as described by Kwiatkowska K, et al. [4]. Tissue staining: Filipin has a strong affinity for cholesterol, but it photobleaches quickly and only produces adapted natural fluorescence in response to brief excitations, making it challenging to detect with confocal panels [5]. Reid PC et al. identified cholesterol buildup in neurons using Filipin III. For two hours, NPC cerebellar tissue was stained with Filipin III (125 μg/ml) while being shielded from light from the front and bottom. Wash the slides together with 0.5 M Tris in clear FBS, then use fluorescent stains for the counterstain. Day 22 saw the development of cholesterol buildup in Purkinje neuron cells. Alternatively, NPC images were stained with Filipin III. On day 22, most neurons showed signs of cholesterol accumulation in the axon hillock area [5]. Novak A et al. employed Filipin III to identify cholesterol accumulation in malignancies. To make a working solution containing 50 μg/mL, dissolve Filipin III in dimethyl sub-solution/PBS (1:4). And place it in front of the tissue slice in the following image. half an hour. The loaded slides were rinsed, and then an aqueous fluorescent mounting media was applied to seal them for observation [6].

[1]. Functional analysis of filipin tailoring genes from Streptomyces filipinensis reveals alternative routes in filipin III biosynthesis and yields bioactive derivatives. Microb Cell Fact. 2015 Aug 7;14:114.

[2]. Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion. Sci Rep. 2014 Dec 23;4:7593.

[3]. Migrasome formation is mediated by assembly of micron-scale tetraspanin macrodomains. Nat Cell Biol. 2019 Aug;21(8):991-1002.

[4]. Visualization of cholesterol deposits in lysosomes of Niemann-Pick type C fibroblasts using recombinant perfringolysin O. Orphanet J Rare Dis. 2014 Apr 28;9:64.

[5]. A novel cholesterol stain reveals early neuronal cholesterol accumulation in the Niemann-Pick type C1 mouse brain. J Lipid Res. 2004 Mar;45(3):582-91.

[6]. Role of the membrane cholesterol-glycosphingolipid complex as a ‘transistor’to regulate GSL receptor function and signaling of both lipids. bioRxiv, 2017: 137612.

A complex of polyene antibiotics obtained from Streptomyces filipinensis. Filipin III alters membrane function by interfering with membrane sterols, inhibits mitochondrial respiration, and is proposed as an antifungal agent. Filipins I, II, and IV are less important.

C35H58O11

654.82842

654.397

480-49-9

5351457

Light yellow to yellow solid powder

1.2±0.1 g/cm3

913.9±65.0 °C at 760 mmHg

163-180°C

279.3±27.8 °C

0.0±0.6 mmHg at 25°C

1.536

-0.41

9

11

5

46

991

0

CCCCCC(C1C(CC(CC(CC(CC(CC(CC(/C(=C\C=C/C=C/C=C/C=C/C(C(OC1=O)C)O)/C)O)O)O)O)O)O)O)O

IMQSIXYSKPIGPD-JUDYZCJOSA-N

InChI=1S/C35H58O11/c1-4-5-11-16-31(42)34-33(44)22-29(40)20-27(38)18-25(36)17-26(37)19-28(39)21-32(43)23(2)14-12-9-7-6-8-10-13-15-30(41)24(3)46-35(34)45/h6-10,12-15,24-34,36-44H,4-5,11,16-22H2,1-3H3/b7-6+,10-8+,12-9-,15-13+,23-14-

(17Z,19Z,21E,23E,25E)-4,6,8,10,12,14,16,27-octahydroxy-3-(1-hydroxyhexyl)-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

2934.99.9001

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples

Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

---

Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).

View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10： 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)

---

Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).

View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders

---

Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

---

 (Please use freshly prepared in vivo formulations for optimal results.)